Organogenesis Holdings (ORGO) Intangibles (2017 - 2026)
Organogenesis Holdings (ORGO) posted quarterly Intangibles of $3.4 million for Q1 2026, down 70.44% year-over-year from $11.6 million in Q1 2025, and down 62.42% quarter-over-quarter from $9.1 million in Q4 2025.
Organogenesis Holdings (ORGO) Intangibles (2017 - 2026) Analysis & Trends
Organogenesis Holdings' Intangibles history runs 10 years deep, the most recent figure standing at $3.4 million for Q1 2026.
- In Q1 2026, Intangibles fell 70.44% year-over-year to $3.4 million; the TTM figure through Mar 2026 stood at $3.4 million (down 70.44% YoY), while the FY2025 annual figure was $9.1 million, down 26.65% from the prior year.
- Intangibles for Q1 2026 stood at $3.4 million, down from $9.1 million in the prior quarter.
- The five-year high for Intangibles was $24.5 million in Q1 2022, with the low at $3.4 million in Q1 2026.
- The 5-year median for Intangibles is $15.0 million (2024), against an average of $15.4 million.
- The sharpest annual moves came in 2022 and 2026: Intangibles slipped 16.77% in 2022, then tumbled 70.44% in 2026.
- Organogenesis Holdings' Intangibles stood at $20.8 million in 2022, then dropped by 23.66% to $15.9 million in 2023, then declined by 21.44% to $12.5 million in 2024, then decreased by 26.65% to $9.1 million in 2025, then plunged by 62.42% to $3.4 million in 2026.
- Business Quant data shows ORGO's Intangibles at $3.4 million in Q1 2026, $9.1 million in Q4 2025, and $9.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 3.45 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 918.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 21.28 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 13.68 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 2.23 Bn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 3.20 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 1.12 Bn |
| 10 | Organogenesis Holdings | 240.62 Mn | 193.78 Mn | 20.08 Mn | 3.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.00 Mn |
| Mar 31, 2026 | 3.44 Mn |
| Dec 31, 2025 | 9.15 Mn |
| Sep 30, 2025 | 9.94 Mn |
| Jun 30, 2025 | 10.79 Mn |
| Mar 31, 2025 | 11.63 Mn |
| Dec 31, 2024 | 12.47 Mn |
| Sep 30, 2024 | 13.30 Mn |
| Jun 30, 2024 | 14.14 Mn |
| Mar 31, 2024 | 14.97 Mn |
| Dec 31, 2023 | 15.87 Mn |
| Sep 30, 2023 | 17.10 Mn |
| Jun 30, 2023 | 18.33 Mn |
| Mar 31, 2023 | 19.56 Mn |
| Dec 31, 2022 | 20.79 Mn |
| Sep 30, 2022 | 22.01 Mn |
| Jun 30, 2022 | 23.23 Mn |
| Mar 31, 2022 | 24.45 Mn |
| Dec 31, 2021 | 25.67 Mn |
| Sep 30, 2021 | 26.90 Mn |